Abyssinia Biosciences

Biotechnology Research • 855 Boylston St, Suite 1000, United States • 1-10 Employees

Company overview

Headquarters	855 Boylston St, Suite 1000, Boston, Massachusetts 02199, US
Website	aby-bio.com
NAICS	541714
Keywords	Biotechnology, Dementia, Immunology, CNS, Neurodegeneration, Alzheimer'S Disease, Neurodegenerative Disease, Alzheimer'S Diagnostics
Founded	2017
Employees	1-10
Socials

Key Contact at Abyssinia Biosciences

Trebor Lawton

Co-Founder

Abyssinia Biosciences Email Formats

Abyssinia Biosciences uses 1 email format. The most common is {first initial} (e.g., j@aby-bio.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@aby-bio.com	100%

About Abyssinia Biosciences

On a mission to eradicate neurodegenerative diseases through the precision targeting of toxic misfolded protein aggregates. Our lead candidates ABY-1125 and ABY-1220 are a monoclonal antibodies (mAbs) that selectively bind to the toxic misfolded forms of amyloid-beta. In preclinical studies, ABY-1125 has shown significantly greater selectivity for toxic oligomers in AD brain samples than other amyloid-targeting antibodies therapies currently in clinical development. Moreover, our data confirm that ABY-1125 and ABY-1220 bind to epitopes that are only present in oligomers and that no other mAbs bind to.

Abyssinia Biosciences revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	$761,500

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Abyssinia Biosciences has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Explore Abyssinia Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-02-01	9	$11,500
2024-02-01	3	$750,000

Funding Insights

$761,500

Total funding amount

$750,000

Most recent funding amount

Number of funding rounds

Abyssinia Biosciences Tech Stack

Discover the technologies and tools that power Abyssinia Biosciences's digital infrastructure, from frameworks to analytics platforms.

jQuery

JavaScript libraries

Underscore.js

JavaScript libraries

Nginx

Reverse proxies

Lightbox

JavaScript libraries

PHP

Programming languages

Bluehost

Hosting

Font Awesome

Font scripts

WordPress

Blogs

WPForms

Form builders

OceanWP

WordPress themes

MySQL

Databases

Elementor

Page builders

Frequently asked questions

Abyssinia Biosciences is located in 855 Boylston St, Suite 1000, US.

Abyssinia Biosciences was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Abyssinia Biosciences has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Abyssinia Biosciences has raised a total of $761,500 across 2 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Abyssinia Biosciences

Trebor Lawton

Co-Founder

4.8

40,000 users